Free tool
Rare disease stocks
We cover 79 companies grouped under the Rare disease theme. The median market value in the group is $47.63M. Across the group, the median move over the past trading day is −0.71%. 38% of the 76 with a 200-day average trade above it. Price change over the past year runs from −87.6% to +106.5% across the middle 80 percent of the group, with a median of −27.3%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
79 of 268 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| VX1.DE | Vertex Pharmaceuticals Incorporated | 472.50 EUR | +9.63% | +22.90% | +41.04% |
| VRTX | Vertex Pharmaceuticals Incorporated | $547.29 | +11.60% | +21.05% | +40.66% |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $540.00 | −1.52% | +20.10% | +37.72% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $239.00 | −17.13% | −40.28% | −47.38% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 62.25 BRL | −15.31% | −44.14% | −49.35% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | 206.90 EUR | +16.24% | −39.34% | −8.93% |
| INSM | Insmed Incorporated | $124.39 | +19.46% | −29.77% | −7.54% |
| ROIV | Roivant Sciences Ltd. | $36.75 | +8.60% | +67.58% | +206.51% |
| JAZZ | Jazz Pharmaceuticals plc | $249.29 | −2.97% | +43.97% | +100.35% |
| ASND | Ascendis Pharma A/S | $250.25 | −1.65% | +17.33% | +29.66% |
| BBIO | BridgeBio Pharma, Inc. | $79.37 | −7.22% | +1.45% | +60.05% |
| CORT | Corcept Therapeutics Incorporated | $119.80 | +27.19% | +213.61% | +71.81% |
| 0JAV.L | Insmed Incorporated | $122.00 | −1.98% | −30.00% | −9.79% |
| BMRN | BioMarin Pharmaceutical Inc. | $65.61 | +5.70% | +10.36% | +11.85% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.33% | +10.68% | +2.58% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $89.12 | +3.89% | +31.46% | +308.99% |
| CYTK | Cytokinetics, Incorporated | $79.20 | −0.31% | +28.30% | +109.36% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.36 | +14.58% | −20.47% | +48.21% |
| KYMR | Kymera Therapeutics, Inc. | $125.55 | +18.26% | +72.55% | +197.09% |
| 0JDI.L | Ionis Pharmaceuticals, Inc. | $62.60 | +2.19% | −20.70% | +48.29% |
| ABVX.PA | ABIVAX Société Anonyme | 100.40 EUR | −7.47% | −12.70% | +46.14% |
| 0RAG.L | ABIONYX Pharma SA | 1.97 EUR | +1.44% | −49.37% | −42.25% |
| FBIO | Fortress Biotech, Inc. | $2.81 | −17.11% | −30.27% | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $2.09 | +5.03% | −94.03% | −94.03% |
| ILA.AX | Island Pharmaceuticals Limited | 0.44 AUD | +14.29% | +1.15% | +100.00% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | 0.21 AUD | +31.25% | −38.24% | −28.81% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| STX.L | Shield Therapeutics plc | 6.04 GBP | +37.27% | −38.68% | −13.71% |
| GOSS | Gossamer Bio, Inc. | $0.17 | −15.17% | −93.96% | −92.93% |
| RCE.AX | Recce Pharmaceuticals Ltd | 0.38 AUD | 0.00% | −43.82% | −10.71% |
| TELO | Telomir Pharmaceuticals, Inc. | $1.17 | −0.85% | −12.69% | −20.95% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.15 EUR | +0.97% | +82.82% | +61.48% |
| FBIOP | Fortress Biotech, Inc. | $18.40 | −1.92% | +81.10% | +131.74% |
| SPRO | Spero Therapeutics, Inc. | $1.22 | +2.09% | −48.09% | −38.38% |
| RNTX | Rein Therapeutics Inc. | $0.80 | +2.30% | −36.00% | −27.27% |
| IMA | ImageneBio, Inc. | $5.43 | −5.73% | −19.67% | −60.19% |
| SCYX | SCYNEXIS, Inc. | $5.67 | +56.20% | +787.32% | +579.04% |
| ATYR | aTyr Pharma, Inc. | $0.55 | +11.54% | −27.40% | −89.34% |
| MCRB | Seres Therapeutics, Inc. | $4.76 | −0.83% | −68.58% | −74.79% |
| EDSA | Edesa Biotech, Inc. | $4.94 | −0.60% | +229.33% | +105.83% |
| GRCE | Grace Therapeutics, Inc. | $2.15 | −4.44% | −41.26% | −29.97% |
| MREO | Mereo BioPharma Group plc | $0.28 | −10.03% | −45.49% | −84.20% |
| BOT.AX | Botanix Pharmaceuticals Limited | 0.02 AUD | 0.00% | −85.19% | −86.21% |
| NNVC | NanoViricides, Inc. | $1.28 | −20.50% | +5.79% | −9.86% |
| QNCX | Quince Therapeutics, Inc. | $31.31 | +61.64% | +4.37% | +100.71% |
| IMM.L | ImmuPharma plc | 3.52 GBP | −5.00% | −43.31% | +57.98% |
| 520A.T | J-PHARMACEUTICALS CO LTD | 295.00 JPY | +13.03% | −57.86% | −57.86% |
| ALDVI.PA | Advicenne S.A. | 1.71 EUR | −1.95% | −8.16% | +36.15% |
| BRNS | Barinthus Biotherapeutics plc | $0.71 | +23.93% | −3.89% | −38.04% |
| 0RQJ.L | Saniona AB (publ) | 11.91 SEK | +1.40% | −43.55% | −11.25% |
| RVX.TO | Resverlogix Corp. | 0.10 CAD | 0.00% | 0.00% | 0.00% |
| JSPR | Jasper Therapeutics, Inc. | $0.72 | +13.43% | −60.98% | −75.24% |
| TVRD | Tvardi Therapeutics, Inc. | $1.78 | −27.05% | −56.37% | −94.18% |
| COCP | Cocrystal Pharma, Inc. | $1.12 | +20.43% | +13.13% | −27.74% |
| KTTA | Pasithea Therapeutics Corp. | $0.57 | +26.67% | −52.10% | −24.30% |
| CALC | CalciMedica, Inc. | $0.59 | −18.18% | −91.28% | −79.74% |
| 4881.T | FunPep Company Limited | 53.00 JPY | +15.22% | −34.57% | −53.91% |
| HIND | Vyome Holdings, Inc. | $2.16 | +8.54% | −39.15% | −79.68% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $5.18 | +23.33% | −63.21% | −29.81% |
| ALBPS.PA | Biophytis S.A. | 0.07 EUR | +387.58% | +19.74% | −55.65% |
| ANNX.ST | Annexin Pharmaceuticals AB (publ) | 13.65 SEK | +5.00% | −31.41% | −45.40% |
| PHR.WA | Pharmena S.A. | 3.14 PLN | +1.95% | +18.49% | −8.19% |
| IMRN | Immuron Limited | $1.14 | +4.11% | +43.40% | −35.77% |
| IMC.AX | Immuron Limited | 0.04 AUD | +8.82% | +5.71% | −47.14% |
| SNGX | Soligenix, Inc. | $0.38 | +6.67% | −72.96% | −87.20% |
| XCUR | Exicure, Inc. | $1.26 | −27.59% | −77.42% | −77.93% |
| VBS.AX | Vectus Biosystems Limited | 0.19 AUD | +42.31% | +12.12% | +122.89% |
| INM | InMed Pharmaceuticals Inc. | $1.43 | −14.37% | +27.68% | −36.44% |
| PULM | Pulmatrix, Inc. | $1.53 | −9.23% | −32.52% | −68.62% |
| JAGX | Jaguar Health, Inc. | $0.92 | −4.63% | −97.37% | −98.52% |
| BIOSGN.ST | Biosergen AB (publ) | 2.00 SEK | +204.37% | −95.00% | −95.53% |
| GRI | GRI Bio, Inc. | $1.91 | +33.57% | −75.64% | −95.23% |
| XRTX | XORTX Therapeutics Inc. | $2.22 | +8.20% | −22.18% | −43.99% |
| BIT.AX | Biotron Limited | 0.00 AUD | 0.00% | −42.86% | −42.86% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $1.08 | −28.00% | −47.67% | −78.23% |
| MTNB | Matinas BioPharma Holdings, Inc. | $0.20 | −32.97% | −68.32% | −90.08% |
| APLI.TO | Appili Therapeutics Inc. | 0.02 CAD | +50.00% | −40.00% | −25.00% |
| APTA.ST | Aptahem AB (publ) | 0.52 SEK | −19.69% | −54.81% | −70.17% |
| ALNEV.PA | Neovacs S.A. | 0.43 EUR | −38.76% | +4842.05% | −27.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.